​

Funding Round

Venture Round - Celladon

Venture Round - Celladon

Investment Firm

Overview

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

Announced Date

Feb 15, 2012

Closed on Date

Feb 15, 2012

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

Pfizer Venture Investments

Pfizer Venture Investments

Pfizer Venture Investments is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

7

Investor Name
Participant InvestorJohnson & Johnson Development Corporation
Participant InvestorNovartis Venture Fund
Participant InvestorGBS Ventures
Participant InvestorVenrock
Participant InvestorEnterprise Partners

Round Details and Background

Celladon raised $43000000 on 2012-02-15 in Venture Round

Celladon is a biotechnology company developing molecular therapies for the treatment of heart failure.

Company Funding History

12

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
May 08, 2012
Venture Round - Celladon
2-10.0M
Feb 15, 2012
Venture Round - Celladon
8-43.0M
Dec 07, 2005
Series B - Celladon
4-30.0M
Nov 01, 2009
Series C - Celladon
3-21.8M

Recent Activity

There is no recent news or activity for this profile.